These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 32291081

  • 1. Preoperative evaluation of mammographic microcalcifications after neoadjuvant chemotherapy for breast cancer.
    Kim EY, Do SI, Yun JS, Park YL, Park CH, Moon JH, Youn I, Choi YJ, Ham SY, Kook SH.
    Clin Radiol; 2020 Aug; 75(8):641.e19-641.e27. PubMed ID: 32291081
    [Abstract] [Full Text] [Related]

  • 2. Residual Mammographic Microcalcifications and Enhancing Lesions on MRI After Neoadjuvant Systemic Chemotherapy for Locally Advanced Breast Cancer: Correlation with Histopathologic Residual Tumor Size.
    Kim YS, Chang JM, Moon HG, Lee J, Shin SU, Moon WK.
    Ann Surg Oncol; 2016 Apr; 23(4):1135-42. PubMed ID: 26628432
    [Abstract] [Full Text] [Related]

  • 3. Residual microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer: comparison of the accuracies of mammography and MRI in predicting pathological residual tumor.
    An YY, Kim SH, Kang BJ.
    World J Surg Oncol; 2017 Nov 06; 15(1):198. PubMed ID: 29110671
    [Abstract] [Full Text] [Related]

  • 4. Comparing Accuracy of Mammography and Magnetic Resonance Imaging for Residual Calcified Lesions in Breast Cancer Patients Undergoing Neoadjuvant Systemic Therapy.
    Um E, Kang JW, Lee S, Kim HJ, Yoon TI, Sohn G, Chung IY, Kim J, Lee JW, Son BH, Ahn SH, Ko BS.
    Clin Breast Cancer; 2018 Oct 06; 18(5):e1087-e1091. PubMed ID: 29703689
    [Abstract] [Full Text] [Related]

  • 5. Histopathologic correlation of residual mammographic microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer.
    Adrada BE, Huo L, Lane DL, Arribas EM, Resetkova E, Yang W.
    Ann Surg Oncol; 2015 Apr 06; 22(4):1111-7. PubMed ID: 25287438
    [Abstract] [Full Text] [Related]

  • 6. Change in microcalcifications on mammography after neoadjuvant chemotherapy in breast cancer patients: correlation with tumor response grade and comparison with lesion extent.
    Yim H, Ha T, Kang DK, Park SY, Jung Y, Kim TH.
    Acta Radiol; 2019 Feb 06; 60(2):131-139. PubMed ID: 29764199
    [Abstract] [Full Text] [Related]

  • 7. Human Epidermal Growth Factor 2-positive Breast Cancer with Mammographic Microcalcification: Relationship to Pathologic Complete Response after Neoadjuvant Chemotherapy.
    Mazari FAK, Sharma N, Dodwell D, Horgan K.
    Radiology; 2018 Aug 06; 288(2):366-374. PubMed ID: 29786482
    [Abstract] [Full Text] [Related]

  • 8. Impact of residual microcalcifcations on prognosis after neoadjuvant chemotherapy in breast cancer patients.
    Kim EY, Lee KH, Yun JS, Park YL, Park CH, Jang SY, Ryu JM, Lee SK, Chae BJ, Lee JE, Kim SW, Nam SJ, Yu JH.
    BMC Womens Health; 2024 Mar 20; 24(1):187. PubMed ID: 38509531
    [Abstract] [Full Text] [Related]

  • 9. Do Decreased Breast Microcalcifications After Neoadjuvant Chemotherapy Predict Pathologic Complete Response?
    Fushimi A, Kudo R, Takeyama H.
    Clin Breast Cancer; 2020 Feb 20; 20(1):e82-e88. PubMed ID: 31255548
    [Abstract] [Full Text] [Related]

  • 10. Correlation of Mammographic Microcalcifications with Final Surgical Pathology After Neoadjuvant Chemotherapy for Breast Cancer.
    Azam R, Lim D, Curpen B, Mulligan AM, Hong NL.
    Ann Surg Oncol; 2023 Jul 20; 30(7):4123-4131. PubMed ID: 37029866
    [Abstract] [Full Text] [Related]

  • 11. MRI prediction of neoadjuvant chemotherapy response is equivalent in patients with or without mammographic calcifications: a step towards adapting surgical approach?
    Sella T, Simor B, Adler-Levy Y, Maly B, Kadouri L, Carmon E.
    Eur Radiol; 2023 Oct 20; 33(10):7168-7177. PubMed ID: 37086288
    [Abstract] [Full Text] [Related]

  • 12. Pre-treatment MRI tumor features and post-treatment mammographic findings: may they contribute to refining the prediction of pathologic complete response in post-neoadjuvant breast cancer patients with radiologic complete response on MRI?
    Thompson BM, Chala LF, Shimizu C, Mano MS, Filassi JR, Geyer FC, Torres US, de Mello GGN, da Costa Leite C.
    Eur Radiol; 2022 Mar 20; 32(3):1663-1675. PubMed ID: 34716780
    [Abstract] [Full Text] [Related]

  • 13. Defining radiologic complete response using a correlation of presurgical ultrasound and mammographic localization findings with pathological complete response following neoadjuvant chemotherapy in breast cancer.
    Makanjuola DI, Alkushi A, Al Anazi K.
    Eur J Radiol; 2020 Sep 20; 130():109146. PubMed ID: 32673929
    [Abstract] [Full Text] [Related]

  • 14. Prediction of Residual Malignancy After Excisional Biopsy for Breast Cancer With Suspicious Microcalcifications: Comparison of Mammography and Magnetic Resonance Imaging.
    Park G, Bae K, Hwang IY, Kim JS, Kwon WJ, Bang M.
    Clin Breast Cancer; 2019 Dec 20; 19(6):e753-e758. PubMed ID: 31182403
    [Abstract] [Full Text] [Related]

  • 15. Magnetic Resonance Imaging after Completion of Neoadjuvant Chemotherapy Can Accurately Discriminate between No Residual Carcinoma and Residual Ductal Carcinoma In Situ in Patients with Triple-Negative Breast Cancer.
    Park S, Yoon JH, Sohn J, Park HS, Moon HJ, Kim MJ, Kim EK, Kim SI, Park BW.
    PLoS One; 2016 Dec 20; 11(2):e0149347. PubMed ID: 26866475
    [Abstract] [Full Text] [Related]

  • 16. Contrast-enhanced MR imaging in patients with BI-RADS 3-5 microcalcifications.
    Cilotti A, Iacconi C, Marini C, Moretti M, Mazzotta D, Traino C, Naccarato AG, Piagneri V, Giaconi C, Bevilacqua G, Bartolozzi C.
    Radiol Med; 2007 Mar 20; 112(2):272-86. PubMed ID: 17361370
    [Abstract] [Full Text] [Related]

  • 17. Value of mammographic microcalcifications and MRI-enhanced lesions in the evaluation of residual disease after neoadjuvant therapy for breast cancer.
    Zhu C, Chen M, Liu Y, Li P, Ye W, Ye H, Ye Y, Liu Z, Liang C, Liu C.
    Quant Imaging Med Surg; 2023 Sep 01; 13(9):5593-5604. PubMed ID: 37711784
    [Abstract] [Full Text] [Related]

  • 18. Chemotherapy may eradicate ductal carcinoma in situ (DCIS) but not the associated microcalcifications.
    Goldberg H, Zandbank J, Kent V, Leonov-Polak M, Livoff A, Chernihovsky A, Guindy M, Evron E.
    Eur J Surg Oncol; 2017 Aug 01; 43(8):1415-1420. PubMed ID: 28526187
    [Abstract] [Full Text] [Related]

  • 19. Is breast MRI a helpful additional diagnostic test in suspicious mammographic microcalcifications?
    Baltzer PAT, Bennani-Baiti B, Stöttinger A, Bumberger A, Kapetas P, Clauser P.
    Magn Reson Imaging; 2018 Feb 01; 46():70-74. PubMed ID: 29122667
    [Abstract] [Full Text] [Related]

  • 20. Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging.
    Iotti V, Ravaioli S, Vacondio R, Coriani C, Caffarri S, Sghedoni R, Nitrosi A, Ragazzi M, Gasparini E, Masini C, Bisagni G, Falco G, Ferrari G, Braglia L, Del Prato A, Malavolti I, Ginocchi V, Pattacini P.
    Breast Cancer Res; 2017 Sep 11; 19(1):106. PubMed ID: 28893303
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.